These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 19719730

  • 1. Chronic allograft nephropathy--a clinical syndrome: early detection and the potential role of proliferation signal inhibitors.
    Campistol JM, Boletis IN, Dantal J, de Fijter JW, Hertig A, Neumayer HH, Oyen O, Pascual J, Pohanka E, Ruiz JC, Scolari MP, Stefoni S, Serón D, Sparacino V, Arns W, Chapman JR.
    Clin Transplant; 2009; 23(6):769-77. PubMed ID: 19719730
    [Abstract] [Full Text] [Related]

  • 2. Everolimus in clinical practice--renal transplantation.
    Pascual J.
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii18-23. PubMed ID: 16815852
    [Abstract] [Full Text] [Related]

  • 3. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy.
    Falger JC, Mueller T, Arbeiter K, Boehm M, Regele H, Balzar E, Aufricht C.
    Pediatr Transplant; 2006 Jun; 10(4):474-8. PubMed ID: 16712606
    [Abstract] [Full Text] [Related]

  • 4. [Replacing calcineurin inhibitors with proliferation signal inhibitors after kidney transplantation: indications, results, and disadvantages].
    Audard V.
    Nephrol Ther; 2009 Dec; 5 Suppl 6():S395-9. PubMed ID: 20129452
    [Abstract] [Full Text] [Related]

  • 5. Five-year follow-up after late conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.
    Krüger B, Fischereder M, Jauch KW, Graeb C, Hoffmann U, Böger CA, Banas B, Obed A, Schlitt HJ, Krämer BK.
    Transplant Proc; 2007 Mar; 39(2):518-21. PubMed ID: 17362772
    [Abstract] [Full Text] [Related]

  • 6. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Wali RK, Weir MR.
    Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
    [Abstract] [Full Text] [Related]

  • 7. Potential therapeutic interventions to avoid or treat chronic allograft dysfunction.
    Kahan BD.
    Transplantation; 2001 Jun 15; 71(11 Suppl):SS52-7. PubMed ID: 11583490
    [Abstract] [Full Text] [Related]

  • 8. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B, Karakayali H, Colak T, Sevmis S, Pehlivan S, Demirhan B, Haberal M.
    Transplant Proc; 2009 Sep 15; 41(7):2789-93. PubMed ID: 19765436
    [Abstract] [Full Text] [Related]

  • 9. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov 15; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 10. Proliferation signal inhibitors and cardiac allograft vasculopathy.
    Raichlin E, Kushwaha SS.
    Curr Opin Organ Transplant; 2008 Oct 15; 13(5):543-50. PubMed ID: 19060540
    [Abstract] [Full Text] [Related]

  • 11. Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy.
    Chapman JR, Valantine H, Albanell J, Arns WA, Campistol JM, Eisen H, Frigerio M, Lehmkuhl H, Marcen R, Morris R, Nashan B, Pascual J, Pohanka E, Segovia J, Zuckermann A.
    Transplant Proc; 2007 Dec 15; 39(10):2937-50. PubMed ID: 18089298
    [Abstract] [Full Text] [Related]

  • 12. Can mTOR inhibitors reduce the risk of late kidney allograft failure?
    Ponticelli C.
    Transpl Int; 2008 Jan 15; 21(1):2-10. PubMed ID: 17635837
    [Abstract] [Full Text] [Related]

  • 13. Chronic renal allograft injury: early detection, accurate diagnosis and management.
    Pascual J, Pérez-Sáez MJ, Mir M, Crespo M.
    Transplant Rev (Orlando); 2012 Oct 15; 26(4):280-90. PubMed ID: 22902496
    [Abstract] [Full Text] [Related]

  • 14. [Proliferation signal inhibitors: what therapeutic protocols are followed in 2009?].
    Ladrière M.
    Nephrol Ther; 2009 Dec 15; 5 Suppl 6():S385-9. PubMed ID: 20129450
    [Abstract] [Full Text] [Related]

  • 15. Post-transplant lymphoproliferative disorder--the potential of proliferation signal inhibitors.
    Pascual J.
    Nephrol Dial Transplant; 2007 May 15; 22 Suppl 1():i27-35. PubMed ID: 17456616
    [Abstract] [Full Text] [Related]

  • 16. Clinical recommendations for the use of everolimus in heart transplantation.
    Manito N, Delgado JF, Crespo-Leiro MG, González-Vílchez F, Almenar L, Arizón JM, Díaz B, Fernández-Yáñez J, Mirabet S, Palomo J, Rodríguez Lambert JL, Roig E, Segovia J.
    Transplant Rev (Orlando); 2010 Jul 15; 24(3):129-42. PubMed ID: 20619801
    [Abstract] [Full Text] [Related]

  • 17. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.
    De Simone P, Metselaar HJ, Fischer L, Dumortier J, Boudjema K, Hardwigsen J, Rostaing L, De Carlis L, Saliba F, Nevens F.
    Liver Transpl; 2009 Oct 15; 15(10):1262-9. PubMed ID: 19790150
    [Abstract] [Full Text] [Related]

  • 18. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
    Campistol JM, Schena FP.
    Nephrol Dial Transplant; 2007 May 15; 22 Suppl 1():i17-22. PubMed ID: 17456614
    [Abstract] [Full Text] [Related]

  • 19. Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure.
    Carmellini M, Collini A, Ruggieri G, Garosi G, Bernini M.
    Transplant Proc; 2008 May 15; 40(6):1858-61. PubMed ID: 18675070
    [Abstract] [Full Text] [Related]

  • 20. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation.
    de Fijter JW.
    Nephrol Dial Transplant; 2007 May 15; 22 Suppl 1():i23-6. PubMed ID: 17456615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.